The disablement process in rheumatoid arthritis

Arthritis Care and Research

Volumn 47, Issue 3, 2002, Pages 333-342

  Escalante, Agustín ^a   Del Rincón, Inmaculada ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ECONOMIC ASPECT; HUMAN; PHYSICAL DISABILITY; QUALITY OF LIFE; REMISSION; RHEUMATOID ARTHRITIS;

EID: 0037097849     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10418     Document Type: Article

References (126)

1. Severe functional declines, work disability and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
2. Update on work disability in rheumatic diseases
3. The work dynamics of the person with rheumatoid arthritis
4. The costs of rheumatoid arthritis
5. The costs of rheumatoid arthritis: Absolute, incremental, and marginal estimates
6. The development of disability in rheumatoid arthritis
7. Measures of functional ability (disability) in arthritis in relation to impairment of range of joint movement
8. Predictors of functional disability in patients with rheumatoid arthritis
9. Relationship between physical impairment, psychological variables and pain in rheumatoid disability: An analysis of their relative impact
10. Relationship of changes in helplessness and depression to disease activity in rheumatoid arthritis
11. An analysis of the relationship between psychological morbidity and disease activity in rheumatoid arthritis
12. Formal education level as a significant marker of clinical status in rheumatoid arthritis
13. Rheumatoid arthritis and comorbidity
14. The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis
15. Formal education as a marker of increased mortality and morbidity in rheumatoid arthritis
16. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis?
17. Disability concepts revisited: Implications for prevention
18. The disablement process
19. Cytokines and cytokine antagonists in rheumatoid arthritis
20. Interleukin 1 beta, hand and foot bone mineral content and the development of joint erosions in rheumatoid arthritis
21. Rheumatoid cachexia: Depletion of lean body mass in rheumatoid arthritis: Possible association with tumor necrosis factor
22. Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
23. Levels of circulating tumor necrosis factor α and interleukin-6 in patients with rheumatoid arthritis: Relationship to serum levels of hyaluran and antigenic keratan sulfate
24. Tumor necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis
25. Laboratory markers of inflammation
26. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis
27. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
28. The relationship between serial measures of disease activity and outcome in rheumatoid arthritis
29. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants
30. Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: Long term course and association to radiographic progression
31. Rheumatoid arthritis: Diagnosis, clinical manifestations, and prognosis
32. Methods of scoring radiographs
33. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films
34. Radiological signs of rheumatoid arthritis: A study of observer differences in the reading of hand films
35. Methods of scoring the progression of radiological changes in rheumatoid arthritis: Correlation of radiologic, clinical, and laboratory abnormalities
36. Methods of assessing radiographic change in rheumatoid arthritis
37. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis
38. Arthritis of the finger joints: A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound and contrast-enhanced magnetic resonance imaging
39. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: A controlled Magnetic Resonance Imaging Study
40. Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained by needle biopsy
41. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
42. The joint alignment and motion scale: A simple measure of joint deformity in patient with rheumatoid arthritis
43. Validity of a simple count of deformed joint as a measure of damage in rheumatoid arthritis
44. Cross-cultural adaptation of a brief outcome questionnaire for Spanish-speaking arthritis patients
45. Rheumatoid nodules: Review of the spectrum of associated conditions and proposal of a new classification, with report of four seronegative cases
46. Course and characteristics of anemia in patients with rheumatoid arthritis of recent onset
47. Rheumatoid arthritis lung disease: Determinants of radiographic and physiologic abnormalities
48. The extra-articular manifestations of rheumatoid arthritis
49. Physical performance measures in aging research
50. Rheumatology function tests: Grip strength, walking time, button test and questionnaires document and predict longterm morbidity and mortality in rheumatoid arthritis
51. A short questionnaire for the measurement of habitual physical activity in epidemiological studies
52. Therapeutic criteria in rheumatoid arthritis
53. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
54. Measurement of patient outcome in arthritis
55. Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire
56. Measuring health status in arthritis: The arthritis impact measurement scales
57. The MACTAR questionnaire - An individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis
58. Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors
59. The influence of sex on the phenotype of rheumatoid arthritis
60. Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant
61. A comparison of three indicators for identifying Mexican Americans in epidemiologic research
62. The genetic contribution to the pathogenesis of rheumatoid arthritis
63. The test of functional health literacy in adults: A new instrument for measuring patients' literacy skills
64. The relationship between socioeconomic status and recently diagnosed rheumatoid arthritis
65. The relationship between self-reported pain and sociodemographic variables, anxiety, and depressive symptoms in rheumatoid arthritis
66. Gender, paid work, and symptoms of emotional distress in rheumatoid arthritis patients
67. The social environment and health in rheumatoid arthritis: Marital quality predicts individual variability in pain severity
68. Association of social support and the spouse's reaction with psychological distress in male and female patients with rheumatoid arthritis
69. Marriage, social support, and adjustment to rheumatic disease
70. Depression symptomatology and psychological distress among Hispanics with rheumatoid arthritis
71. Assessment of psychological outcomes and quality of life in the rheumatic diseases
72. Compliance to drug treatment of patients with rheumatoid arthritis: A 3 year longitudinal study
73. Self-efficacy and health
74. Development and evaluation of a scale to measure perceived selfefficacy in people with arthritis
75. Outcomes of self-help education for patients with arthritis
76. Failure to escape traumatic shock
77. The measurement of helplessness in rheumatoid arthritis: The development of the arthritis helplessness index
78. A dual pathway model of daily stressor effects on rheumatoid arthritis
79. Disease and psychosocial factors related to physical functioning in rheumatoid arthritis
80. Formal education and five-year mortality in rheumatoid arthritis: Mediation by helplessness scale score
81. Coping with rheumatoid arthritis pain: Catastrophizing as a maladaptive strategy
82. Effects of stress on the immune system
83. Temporal covariation of soluble interleukin-2 receptor levels, daily stress, and disease activity in rheumatoid arthritis
84. Examination of changes in interpersonal stress as a factor in disease exacerbations among women with rheumatoid arthritis
85. Effects of stress management on clinical outcomes in RA
86. Stress and cardiovascular health: An international cooperative study. I
87. Stress and cardiovascular health: An international cooperative study. II. The male population at a factory in Zurich
88. Direct and buffer effects of social support and personal coping resources in individuals with arthritis
89. The effects of social support on the relationship of functional limitations and pain to depression
90. The MOS social support survey
91. Comorbidity in arthritis
92. Mortality among arthritis
93. Increased mortality in rheumatoid arthritis
94. Cause of death in rheumatoid arthritis
95. Cardiovascular mortality in patients with rheumatoid arthritis
96. Cardiovascular mortality in women with rheumatoid arthritis
97. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events
98. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
99. Can comorbidity be measured by questionnaire rather than by medical record review?
100. The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity
101. Reducing work disability associated with rheumatoid arthritis: Identification of additional risk factors and persons likely to benefit from intervention
102. The influence of the social environment on the social participation of people with disabilities
103. Substance P and arthritis: Analysis of plasma and synovial fluid levels
104. Rheumatoid arthritis and depression: An overview
105. Cognitive distortion, helplessness, and depressed mood in rheumatoid arthritis: A four-year longitudinal analysis
106. Pain coping strategies and depression in rheumatoid arthritis
107. Type of stressor and depressive mood in patients with rheumatoid arthritis
108. An inventory for measuring depression
109. The CES-D scale: A self-report depression scale for research in the general population
110. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: A randomized trial
111. Positive impact of an intervention by arthritis patient educators on knowledge and satisfaction of patients in a rheumatology practice
112. Education, self-care, and outcomes of rheumatic diseases: Further challenges to the "biomedical model" paradigm
113. Disease and psychosocial factors related to physical functioning in rheumatoid arthritis
114. Predictors of functional disability in rheumatoid arthritis
115. Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration
116. Preliminary definition of improvement in rheumatoid arthritis
117. Which traditional measures should be used in rheumatoid arthritis clinical trials?